Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists-Reference-Cited by-同舟云学术

Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists

Published:2016-06-22 Issue:13 Volume:59 Page:6149-6168
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Junker Anna¹,Balasubramanian Ramachandran¹,Ciancetta Antonella¹,Uliassi Elisa¹,Kiselev Evgeny¹,Martiriggiano Chiara¹,Trujillo Kevin¹,Mtchedlidze Giorgi¹,Birdwell Leah¹,Brown Kyle A.²,Harden T. Kendall²,Jacobson Kenneth A.¹

Affiliation:

1. Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0810, United States

2. Department of Pharmacology, University of North Carolina, School of Medicine, Chapel Hill, North Carolina 27599, United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Deutsche Forschungsgemeinschaft

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00044

Reference47 articles.

1. UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation